Boryung Pharmaceutical and Roche will co-promote the hepatitis type B and C treatment ‘Pegasys’
Boryung Pharmaceutical and Roche Korea will co-promote the chronic hepatitis type B and C treatment ‘Pegasys’.
Boryung Pharmaceutical (CEO Tae-hong Choi) and Roche Korea (General Manager Mike Crichton) announced on the 29th that they have made a co-promotion contract for the chronic hepatitis ty...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
